The global GLP-1 Receptor Agonist Market reached USD 13.46 Billion in 2022 and is projected to experience a rapid revenue CAGR of 6% throughout the forecast period. The significant drivers of this growth include the introduction of innovative GLP-1 receptor agonist formulations, increasing demand for these medications, and a rising prevalence of type 2 Diabetes. @ https://www.reportsanddata.com/report-detail/glp-1-receptor-agonist-market